Randomised, double blind, placebo controlled, multicentre Study comparing Ciprofoxacin DPI 32.5mg BID intermittently administered for 28 days on /28days off 14 days on /14 days off versus placebo to e
- 鄧, 忠光 (Primary Chief Investigator (PCI))
Project: Research